Nevro received FDA approval for Senza Omnia device, its new spinal cord stimulation system.
Four insights:
1. Senza Omnia delivers Nevro's HF10 therapy as well as other spinal cord stimulation frequencies.
2. It features a programmer that facilitates more waveforms across the spinal cord frequency spectrum.
3. Senza Omnia has a redesigned patient remote, which aims to enhance the patient experience.
4. It also features an updated implantable pulse generator that is designed to last 10 years no matter what simulation profile is used.